Abstract
PURPOSE: We report the downstaging, sphincter preservation, acute toxicity, and preliminary local control and survival results of preoperative 5-fiuorouracil (5-FU), low-dose leucovorin (LV), and concurrent radiation therapy followed by postoperative LV/5-FU for treatment of patients with clinically resectable T3 rectal cancer. MATERIALS AND METHODS: A total of 32 patients received two monthly cycles of preoperative LV/5-FU (bolus daily×5). Radiation therapy (5,040 cGy) began concurrently on day 1. Postoperatively, patients received a median of two monthly cycles of LV/5-FU (range, 0–10). RESULTS: The complete response rate was 9 percent pathologic and 13 percent clinical, for a total of 22 percent. Total Grade 3+ acute toxicity during the preoperative combined modality segment was 25 percent (8/32). Of the 20 patients who were thought to initially require an abdominoperineal resection and for whom the intent of treatment was sphincter preservation, 17 (85 percent) were able to undergo sphincter-preserving surgery. With a median follow-up of 22 (3–59) months, none have developed local failure, and the three-year actuarial diseasefree survival rate was 60 percent. CONCLUSION: Our data reveal encouraging downstaging, sphincter preservation, and acute toxicity with this regimen. Additional follow-up is needed to assess the long-term local control and survival rates.
Similar content being viewed by others
References
National Institutes of Health Consensus Conference. Adjuvant therapy for patients with colon and rectal cancer. J Am Med Assoc 1990;264:1444–50.
Minsky BD, Kemeny N, Cohen AM,et al. Preoperative high-dose leucovorin/5-fluorouracil and radiation therapy for unresectable rectal cancer. Cancer 1991;67:2859–66.
Minsky BD, Cohen AM, Kemeny N,et al. Efficacy of pre-operative 5-FU, high dose leucovorin, and sequential radiation therapy for unresectable rectal cancer. Cancer 1993;71:3486–92.
Minsky BD, Cohen AM, Kemeny N,et al. Pre-operative combined 5-FU, low dose leucovorin, and sequential radiation therapy for unresectable rectal cancer. Int J Radiat Oncol Biol Phys 1993;25:821–7.
Minsky BD, Cohen AM, Enker WE,et al. Pre-operative 5-FU, low dose leucovorin, and concurrent radiation therapy for rectal cancer. Cancer 1993;73:273–8.
Minsky BD, Cohen A, Enker W,et al. Pre-operative 5-FU, low dose leucovorin, and radiation therapy for locally advanced/unresectable rectal cancer. Int J Radiat Oncol Biol Phys (in press).
American Joint Committee on Cancer. Manual for staging of cancer. Philadelphia: JB Lippincott, 1987.
Minsky BD. Pelvic radiation therapy in rectal cancer: technical considerations. Semin Radiat Oncol 1993;3:42–7.
Harrison LB, Enker WE, Anderson LL. High dose intraoperative radiation therapy for colorectal cancer. Oncology 1995;9:679–83.
Kaplan EL, Meier P. Nonparametric estimation for incomplete observation. J Am Stat Assoc 1958;53:457–81.
Meade PG, Blatchford GJ, Thorson AG, Christensen MA, Ternent CA. Preoperative chemoradiation downstages locally advanced ultrasound-staged rectal cancer. Am J Surg 1995;170:609–13.
Picciocchi A, Coco C, Magistrelli P,et al. Concomitant preoperative radiochemotherapy in operable locally advanced rectal cancer. Dis Colon Rectum 1994;37(Suppl):S69–72.
Weinstein GD, Rich TA, Shumate CR,et al. Preoperative infusional chemoradiation and surgery with or without an electron beam intraoperative boost for advanced primary rectal cancer. Int J Radiat Oncol Biol Phys 1995;32:197–204.
Bosset JF, Pavy JJ, Hamers HP,et al. Determination of the optimal dose of 5-fluorouracil when combined with low dose d,l-leucovorin and irradiation in rectal cancer: results of three consecutive phase II studies. Eur J Cancer 1993;29:476–86.
Landry JC, Koretz MJ, Wood WC,et al. Preoperative irradiation and fluorouracil chemotherapy for locally advanced rectosigmoid carcinoma: phase I-II study. Radiology 1993;188:423–6.
Haghbin M, Sischy B, Hinson J. Combined modality therapy in poor prognostic rectal adenocarcinoma. Radiother Oncol 1988;13:75–81.
Chen ET, Mohiuddin M, Brodovsky H, Fishbein G, Marks J. Downstaging of advanced rectal cancer following combined preoperative chemotherapy and high dose radiation. Int J Radiat Oncol Biol Phys 1994;30:169–75.
Cooper SG, Bonaventura A, Ackland SP,et al. Pelvic radiotherapy with concurrent 5-fluorouracil modulated by leucovorin for rectal cancer: a phase II study. Clin Oncol 1993;5:169–73.
Chan A, Wong A, Langevin J, Khoo R. Preoperative concurrent 5-fluorouracil infusion, mitomycin-c and pelvic radiation therapy in tethered and fixed rectal carcinoma. Int J Radiat Oncol Biol Phys 1993;25:791–9.
Frykholm G, Glimelius B, Pahlman L. Preoperative irradiation with and without chemotherapy (MFL) in the treatment of primary non-resectable adenocarcinoma of the rectum: results from two consecutive studies. Eur J Clin Oncol 1989;11:1535–4l.
Chari RS, Tyler DS, Anscher MS,et al. Preoperative radiation and chemotherapy in the treatment of adenocarcinoma of the rectum. Ann Surg 1995;221:778–87.
Rich TA, Skibber JM, Ajani JA, et al. Preoperative infusional chemoradiation therapy for stage T3 rectal cancer. Int J Radiat Oncol Biol Phys 1995;32:1025–9.
Stryker SJ, Kiel KD, Rademaker A, Shaw JM, Ujiki GT, Poticha SM. Preoperative “chemoradiation” for stages II and II rectal carcinoma. Arch Surg 1996;131:514–9.
Willett CG, Warland G, Hagan MP,et al. Tumor proliferation in rectal cancer following preoperative irradiation. J Clin Oncol 1995;13:1417–24.
Minsky BD, Cohen AM, Enker WE, Paty P. Sphincter preservation with preoperative radiation therapy and coloanal anastomosis. Int J Radiat Oncol Biol Phys 1995;31:553–9.
Rouanet P, Fabre JM, Dubois JB,et al. Conservative surgery for low rectal carcinoma after high-dose radiation. Functional and oncologic results. Ann Surg 1995;221:67–73.
Mohiuddin M, Ahmad N, Marks G. A selective approach to adjunctive therapy for cancer of the rectum. Int J Radiat Oncol Biol Phys 1994;27:765–72.
Author information
Authors and Affiliations
About this article
Cite this article
Grann, A., Minsky, B.D., Cohen, A.M. et al. Preliminary results of preoperative 5-fluorouracil, low-dose leucovorin, and concurrent radiation therapy for clinically resectable T3 rectal cancer. Dis Colon Rectum 40, 515–522 (1997). https://doi.org/10.1007/BF02055370
Issue Date:
DOI: https://doi.org/10.1007/BF02055370